1. Home
  2. YDES vs PHR Comparison

YDES vs PHR Comparison

Compare YDES & PHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

YDES

YD Bio Limited Ordinary Shares

HOLD

Current Price

$4.44

Market Cap

543.0M

Sector

N/A

ML Signal

HOLD

Logo Phreesia Inc.

PHR

Phreesia Inc.

HOLD

Current Price

$8.72

Market Cap

583.9M

ML Signal

HOLD

Company Overview

Basic Information
Metric
YDES
PHR
Founded
2013
2005
Country
Taiwan
United States
Employees
N/A
N/A
Industry
Business Services
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
543.0M
583.9M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
YDES
PHR
Price
$4.44
$8.72
Analyst Decision
Buy
Analyst Count
0
18
Target Price
N/A
$21.18
AVG Volume (30 Days)
4.9K
1.2M
Earning Date
05-12-2026
05-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
103.92
EPS
N/A
0.04
Revenue
N/A
$480,591,000.00
Revenue This Year
N/A
$8.43
Revenue Next Year
N/A
$5.10
P/E Ratio
N/A
$218.88
Revenue Growth
N/A
14.48
52 Week Low
$4.37
$7.77
52 Week High
$25.00
$32.76

Technical Indicators

Market Signals
Indicator
YDES
PHR
Relative Strength Index (RSI) 29.81 40.42
Support Level N/A $8.71
Resistance Level $5.37 $12.68
Average True Range (ATR) 0.25 0.46
MACD 0.01 -0.04
Stochastic Oscillator 14.03 17.30

Price Performance

Historical Comparison
YDES
PHR

About YDES YD Bio Limited Ordinary Shares

YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.

About PHR Phreesia Inc.

Phreesia Inc is a provides an integrated software, payments, and engagement platform designed to address three foundational challenges in healthcare delivery: access to care, affordability of care, and patient health outcomes. Its platform is embedded directly into provider workflows and patient interactions, enabling healthcare organizations to activate patients, streamline administrative processes, and improve financial performance across the care continuum. The group serves a diverse group of healthcare organizations, including ambulatory practices, health systems, and hospitals, as well as life sciences companies, government entities, patient advocacy, public interest, and not-for-profit and other organizations.

Share on Social Networks: